단백질체학 바이오마커 분석 시장(제2판) : 용도별, 기술별, 제품별, 장소별 예측 - 경영진 및 컨설턴트 가이드 포함, 인공지능(AI)의 영향(2026-2030년)

Report Overview:

Where genomics can't find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is huge. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size out for five years for a number of different market segments.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1 Market Guides

• 1.1 Situation Analysis
• 1.2 Guide for Executives and Marketing Staff
• 1.3 Guide for Investment Analysts and Management Consultants
• 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

• 2.1 What are Proteomic Biomarker Analytics?
• 2.2 Proteomics and Drug Development
• 2.3 Market Definition
  • 2.3.1 Market Size
  • 2.3.2 Currency
  • 2.3.3 Years
• 2.4 Methodology
  • 2.4.1 Methodology
  • 2.4.2 Sources
  • 2.4.3 Authors

3 Proteomic Biomarker Analytics – Guide to Technologies

• 3.1 Methods
  • 3.1.1 Separation techniques and electrophoresis
  • 3.1.2 Mass spectrometry
  • 3.1.3 Chromatography
  • 3.1.4 Blotting
  • 3.1.5 Protein complementation assays and interaction screens
  • 3.1.6 Protein structure prediction
  • 3.1.7 Protein databases

4 Industry Overview

• 4.1 Players in a Dynamic Market
• 4.2 Academic Research Lab
• 4.3 Diagnostic Test Developer
• 4.4 Instrumentation Supplier
• 4.5 Chemical/Reagent Supplier
• 4.6 Pathology Supplier
• 4.7 Independent Clinical Laboratory
• 4.8 Public National/regional Laboratory
• 4.9 Hospital Laboratory
• 4.10 Physicians Office Lab (POLS)
• 4.11 Audit Body
• 4.12 Certification Body

5 Market Trends

• 5.1 Factors Driving Growth
  • 5.1.1 Drug Development
  • 5.1.2 Companion Dx
  • 5.1.3 Fertile Research
  • 5.1.4 Technology Convergence
• 5.2 Factors Limiting Growth
  • 5.2.1 The Cost Curve
  • 5.2.2 Capacity Constraints
  • 5.2.3 Market Lag

6 Proteomic Analytics Recent Developments

• 6.1 Recent Developments – Importance and How to Use This Section
  • 6.1.1 Importance of These Developments
  • 6.1.2 How to Use This Section
• 6.2 Sapient Partnering With Alamar Bio to Offer Proteomics
• 6.3 Spear Bio Funded for Protein-Based Diagnostics
• 6.4 Salignostics, Sheba Medical Partner on Saliva-Based Cancer Test
• 6.5 Key Proteo Applies for Newborn Screening Kit to FDA
• 6.6 Mass Spec Test to Detect Ovarian Cancer
• 6.7 Proteomic Multiple Sclerosis Test Gaining Traction
• 6.8 Emory U Protein Panel Could Diagnose Alzheimer's Disease
• 6.9 Amprion's Parkinson's Disease Dx Shows Strong Performance
• 6.10 Single-Cell Proteomics Bypasses Bottlenecks
• 6.11 SomaLogic Seeks 'Strategic Alternatives' for Dx Business
• 6.12 Alzheimer's Dx Study to Add Genomic, Proteomic Profiling
• 6.13 NanoDx Prepares for POC Platform Commercialization
• 6.14 DeepMind AI Predicts 3D Structure of Every Protein
• 6.15 Quanterix Slashing Workforce by 25 Percent
• 6.16 Study Shows Potential of NanoMosaic's Platform for Biomarker Development
• 6.17 Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra .. 78
• 6.18 PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications
• 6.19 Octave Bioscience Building Evidence Base for Multiple Sclerosis Test
• 6.20 Proteomics Goes Public

7 Profiles of Key Proteomic Biomarker Analytic Companies

• 7.1 Abbott Laboratories
• 7.2 Abcam
• 7.3 Agilent
• 7.4 Amprion
• 7.5 ATUM
• 7.6 BasePair Biotechnologies
• 7.7 Beckman Coulter Diagnostics (Danaher)
• 7.8 Becton, Dickinson and Company
• 7.9 Biomatik
• 7.10 Bio-Rad Laboratories, Inc
• 7.11 Bio-Techne
• 7.12 Bruker
• 7.13 C2N Diagnostics
• 7.14 Cepheid (Danaher)
• 7.15 Diadem Diagnostics
• 7.16 Eve Technologies
• 7.17 Fujirebio
• 7.18 Hybrigenics Services
• 7.19 MRM Proteomics Inc.
• 7.20 NanoDx
• 7.21 Nautilus Biotechnology
• 7.22 Nicoya
• 7.23 Nuclera
• 7.24 Olink
• 7.25 Qiagen
• 7.26 Quanterix
• 7.27 Roche Diagnostics
• 7.28 Second Genome
• 7.29 Siemens Healthineers
• 7.30 Sphingotec
• 7.31 Thermo Fisher Scientific
• 7.32 Unchained Labs

8 Global Proteomic Analytics Markets

• 8.1 PROTEIN ANALYTICS – Global Market Overview by Country
  • 8.1.1 Table – Global Market by Country
  • 8.1.2 Chart - Global Market by Country
• 8.2 Global Market by Application - Overview
  • 8.2.1 Table – Global Market by Application
  • 8.2.2 Chart – Global Market by Application – Segments Growth
  • 8.2.3 Chart – Global Market by Application – Base/Final Comparison
  • 8.2.4 Chart – Global Market by Application – Base Year
  • 8.2.5 Chart – Global Market by Application – Final Year
  • 8.2.6 Chart – Global Market by Application – Share by Year
• 8.3 Global Market by Technology - Overview
  • 8.3.1 Table – Global Market by Technology
  • 8.3.2 Chart – Global Market by Technology – Segments Growth
  • 8.3.3 Chart – Global Market by Technology – Base/Final Comparison
  • 8.3.4 Chart – Global Market by Technology – Base Year
  • 8.3.5 Chart – Global Market by Technology – Final Year
  • 8.3.6 Chart – Global Market by Technology – Share by Year
• 8.4 Global Market by Product - Overview
  • 8.4.1 Table – Global Market by Product
  • 8.4.2 Chart – Global Market by Product – Segments Growth
  • 8.4.3 Chart – Global Market by Product – Base/Final Comparison
  • 8.4.4 Chart – Global Market by Product – Base Year
  • 8.4.5 Chart – Global Market by Product – Final Year
  • 8.4.6 Chart – Global Market by Product – Share by Year
• 8.5 Global Market by Place - Overview
  • 8.5.1 Table – Global Market by Place
  • 8.5.2 Chart – Global Market by Place – Segments Growth
  • 8.5.3 Chart – Global Market by Place – Base/Final Comparison
  • 8.5.4 Chart – Global Market by Place – Base Year
  • 8.5.5 Chart – Global Market by Place – Final Year
  • 8.5.6 Chart – Global Market by Place – Share by Year

9 Global PROTEIN ANALYTICS Markets – By Application

• 9.1 PROTEIN ANALYTICS Drug Discovery
  • 9.1.1 Table PROTEIN ANALYTICS Drug Discovery – by Country
  • 9.1.2 Chart - PROTEIN ANALYTICS Drug Discovery Growth
• 9.2 PROTEIN ANALYTICS Research Application
  • 9.2.1 Table PROTEIN ANALYTICS Research Application – by Country
  • 9.2.2 Chart - PROTEIN ANALYTICS Research Application Growth
• 9.3 PROTEIN ANALYTICS Clinical Dx
  • 9.3.1 Table PROTEIN ANALYTICS Clinical Dx – by Country
  • 9.3.2 Chart - PROTEIN ANALYTICS Clinical Dx Growth
• 9.4 PROTEIN ANALYTICS Other Applications
  • 9.4.1 Table PROTEIN ANALYTICS Other Applications – by Country
  • 9.4.2 Chart - PROTEIN ANALYTICS Other Applications Growth

10 Global PROTEIN ANALYTICS Markets – By Technology

• 10.1 PROTEIN ANALYTICS Mass Spectrometry
  • 10.1.1 Table PROTEIN ANALYTICS Mass Spectrometry – by Country
  • 10.1.2 Chart - PROTEIN ANALYTICS Mass Spectrometry Growth
  10.2 PROTEIN ANALYTICS ELISA/Beads
  • 10.2.1 Table PROTEIN ANALYTICS ELISA/Beads – by Country
  • 10.2.2 Chart - PROTEIN ANALYTICS ELISA/Beads Growth
• 10.3 PROTEIN ANALYTICS Hybrid Multiplex
  • 10.3.1 Table PROTEIN ANALYTICS Hybrid Multiplex – by Country
  • 10.3.2 Chart - PROTEIN ANALYTICS Hybrid Multiplex Growth
• 10.4 PROTEIN ANALYTICS Other Technology
  • 10.4.1 Table PROTEIN ANALYTICS Other Technology – by Country
  • 10.4.2 Chart - PROTEIN ANALYTICS Other Technology Growth

11 Global PROTEIN ANALYTICS Markets – By Product

• 11.1 PROTEIN ANALYTICS Instruments
  • 11.1.1 Table PROTEIN ANALYTICS Instruments – by Country
  • 11.1.2 Chart - PROTEIN ANALYTICS Instruments Growth
• 11.2 PROTEIN ANALYTICS Kits & Reagents
  • 11.2.1 Table PROTEIN ANALYTICS Kits & Reagents – by Country
  • 11.2.2 Chart - PROTEIN ANALYTICS Kits & Reagents Growth
• 11.3 PROTEIN ANALYTICS Services
  • 11.3.1 Table PROTEIN ANALYTICS Services – by Country
  • 11.3.2 Chart - PROTEIN ANALYTICS Services Growth

12 Global PROTEIN ANALYTICS Markets – By Place

• 12.1 PROTEIN ANALYTICS Academic
  • 12.1.1 Table PROTEIN ANALYTICS Academic – by Country
  • 12.1.2 Chart - PROTEIN ANALYTICS Academic Growth
• 12.2 PROTEIN ANALYTICS Pharma/Biotech
  • 12.2.1 Table PROTEIN ANALYTICS Pharma/Biotech – by Country
  • 12.2.2 Chart - PROTEIN ANALYTICS Pharma/Biotech Growth
• 12.3 PROTEIN ANALYTICS Clinical
  • 12.3.1 Table PROTEIN ANALYTICS Clinical – by Country
  • 12.3.2 Chart - PROTEIN ANALYTICS Clinical Growth
• 12.4 PROTEIN ANALYTICS Other Place
  • 12.4.1 Table PROTEIN ANALYTICS Other Place – by Country
  • 12.4.2 Chart - PROTEIN ANALYTICS Other Place Growth

13 Appendices

• 13.1 Clinical Laboratory Fee Schedule
• 13.2 The Most Used IVD Assays
• 13.3 The Highest Grossing Assays
• 13.4 The Changing IVD Menu
  • 13.4.1 Approved IVD Test Menu History
• 13.5 The Changing Picture on Reimbursement